SISCAPA Assay Technologies
The Stanford researcher and his colleagues have launched a pair of companies, Iollo and RHTM, to commercialize the approach.
The companies said that they envisioned the test, which is currently RUO, as potentially part of a mass spectrometry-based respiratory virus panel.
Highlights included mass spec-focused developments like data-independent acquisition and ion mobility along with platforms including Thermo Fisher's Q Exactive.
While the approach lost some of its luster after failing to deliver on early hype, technological improvements are revitalizing interest among researchers.
Enthusiasm for dried blood spot samples is building among clinical proteomic researchers and companies, but recent work suggests technical hurdles remain.
Feb 10, 2017
Jul 21, 2016
Jan 15, 2016
Jul 23, 2015
May 16, 2014
May 2, 2014
Apr 11, 2014
Mar 14, 2014